The use of 5-alpha-reductase inhibitors for the prevention of prostate cancer

被引：0
|
作者：
Yu, Eun-mi [1 ]
El-Ayass, Walid [1 ]
Aragon-Ching, Jeanny B. [1 ]
机构：
[1] Washington Univ, Dept Med, Div Hematol & Oncol, Med Ctr, Washington, DC USA
来源：
CANCER BIOLOGY & THERAPY | 2010年 / 10卷 / 01期
关键词：
5-alpha-reductase inhibitors; finasteride; dutasteride; prostate cancer; FINASTERIDE;
D O I：
10.4161/cbt.10.1.12368
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The use of 5-alpha-reductase inhibitors has been studied not only in benign prostatic hyperplasia, but as a chemopreventive strategy in prostate cancer. Both finasteride and dutasteride, 5-alpha-reductase inhibitors (SARI), have been shown to decrease the risk for prostate cancer. The results of the REDUCE trial using the dual alpha-reductase isoenzyme inhibitor dutasteride, has recently been published by Andriole et al. in the New England Journal of Medicine. Certain considerations regarding its use and applicability to men with high risk of developing prostate cancer are herein discussed.
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [1] 5-alpha-reductase inhibitors for prostate cancer prevention
    不详
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (06) : 553 - 553
  • [2] 5-ALPHA-REDUCTASE INHIBITION AND PROSTATE-CANCER PREVENTION
    BRAWLEY, OW
    FORD, LG
    THOMPSON, I
    PERLMAN, JA
    KRAMER, BS
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1994, 3 (02) : 177 - 182
  • [3] PROSTATE EFFECTS OF 5-ALPHA-REDUCTASE INHIBITORS
    RASMUSSON, GH
    REYNOLDS, GF
    STEINBERG, NG
    PATEL, GF
    WALTON, E
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 193 : 8 - MEDI
  • [4] 5-Alpha-reductase inhibitors in diseases of the prostate
    Carrasquillo, Robert J.
    Nealy, Sean W.
    Wang, David S.
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (06) : 488 - 492
  • [5] Battling Prostate Cancer with 5-Alpha-Reductase Inhibitors: a Pyrrhic Victory?
    Richard M. Hoffman
    Richard G. Roberts
    Michael J. Barry
    [J]. Journal of General Internal Medicine, 2011, 26 : 798 - 801
  • [6] 5-ALPHA-REDUCTASE INHIBITORS IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Dai, Charles
    Ganesan, Vishnu
    Zabell, Joseph
    Nyame, Yaw
    Hettel, Daniel
    Almassi, Nima
    Greene, Daniel
    Haywood, Samuel
    Reichard, Chad
    Zampini, Anna
    Crane, Alice
    Arora, Hans
    El-Shafei, Ahmed
    Stein, Robert
    Fareed, Khaled
    Gong, Michael
    Jones, J. Stephen
    Stephenson, Andrew
    Klein, Eric
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E229 - E229
  • [7] Battling Prostate Cancer with 5-Alpha-Reductase Inhibitors: a Pyrrhic Victory?
    Hoffman, Richard M.
    Roberts, Richard G.
    Barry, Michael J.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (07) : 798 - 801
  • [8] CHEMOPREVENTION STRATEGIES FOR PROSTATE-CANCER - THE ROLE OF 5-ALPHA-REDUCTASE INHIBITORS
    GORMLEY, GJ
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, : 113 - 117
  • [9] Prostate Cancer Prevention with 5 Alpha-Reductase Inhibitors
    Parekh, Dipen J.
    [J]. CLINICAL CANCER PREVENTION, 2011, 188 : 109 - 114
  • [10] Contraindicated use of 5-alpha-reductase inhibitors in women
    Teichert, Martina
    van Puijenbroek, Eugene
    Stricker, Bruno H.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (02) : 429 - 431
12345